DRKS00011318已完成未知
Randomized, controlled study comparing two mouthwashes with regard to taste assessment and reduction of oral mucosa in oncological patients -Octenidol® vs. Glandomed® - mucoglan
Fa. Schülke GmbH0 个研究点目标入组 93 人开始时间: 2016年11月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 93
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Participants> 18 years
- •Signed declaration of consent to participate or
- •Written declaration of consent by the supervisor
- •German speaking
- •oncological patients (KMT autologous or allogeneic)
排除标准
- •Mental disorders
- •Existing mucositis before radiation therapy / chemotherapy
- •Current therapy with chemotherapy or irradiation
- •Incompatibility with CHX or octenidine
- •Temperatures> 38 degrees Celsius before irradiation / chemotherapy
- •Dental defect or loose teeth
- •Infection of the upper respiratory tract
研究者
相似试验
招募中
不适用
A randomized controlled trial comparing two stuttering reatments in school-age childreDevelopmental stutteringJPRN-UMIN000043239ational Rehabilitation Center for Persons with Disabilities30
进行中（未招募）
不适用
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple MyelomaMultiple MyelomaEUCTR2005-003770-23-SIF. Hoffmann-La Roche Ltd424
进行中（未招募）
1 期
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple MyelomaMultiple MyelomaEUCTR2005-003770-23-GBF. Hoffmann-La Roche Ltd424
进行中（未招募）
不适用
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple MyelomaMultiple MyelomaEUCTR2005-003770-23-EEF. Hoffmann-La Roche Ltd424
进行中（未招募）
1 期
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple MyelomaMultiple MyelomaEUCTR2005-003770-23-SKF. Hoffmann-La Roche Ltd424